NetworkNewsBreaks – Cesca Therapeutics (NASDAQ: KOOL) Spike on Encouraging Data for Chronic Non-Healing Ulcers Treatment
Shares of Cesca Therapeutics’ (NASDAQ: KOOL) are up 12% mid-morning on promising data from a study evaluating the use of autologous platelet rich plasma (PRP) for the treatment of chronic non-healing ulcers. The study, entitled “Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series,” was led by researchers from TotipotentRX, a subsidiary of Cesca Therapeutics, and Fortis Memorial Research Institute. Results from the 24 patient study were published in the peer-reviewed Journal of Biomedical Science. During the study, 24 patients with one wound or ulcer were treated with a single dose of PRP injections around the…